Advertisement
It was a small but telling illustration of the gap between public expectations of the eagerly-anticipated new COVID-19 vaccines and the long, unpredictable road still ahead.
On Wednesday, federal acting Chief Medical Officer, Professor Paul Kelly, revealed that an “old friend” had emailed to see if his daughter, working in intensive care in Britain, might be allowed to return to Australia without quarantine because she’d received a first dose of the Pfizer-BioBTech vaccine – which British authorities had started rolling out only days before. An “interesting” proposition, Kelly said tactfully.
Get that jab: Healthcare workers wait to receive the Pfizer-BioNTech COVID-19 vaccine at UCI Medical Centre in California on Wednesday.
Foreign Exchange Markets continue to see past bad news and both the S&P500 and AUD/USD exchange rate continue to correlate and are at the highs of the year.
Record Covid-19 daily deaths in the US and a fresh Covid outbreak in New South Wales have not dented uptrends.
The robust Australian economy has been able to weather restrictions. It seems the potential trade war with China is the only dark cloud on the horizon.
Friday s session concludes the last full week of trading in 2020. Stocks are slightly lower while the USD is bouncing slightly, but with most risk markets at or near their yearly highs, whatever happens over the remainder of the year isn’t likely to change the bullish look.
Australia and India partner on COVID-19 research
Photo: Unsplash/Prasesh Shiwakoti
AKIPRESS.COM - Australian and Indian researchers will work together to advance COVID-19 screening and study the future health effects of the virus, after a nearly $4 million investment by the Scott Morrison Government, Just Earth news reported.
The Australia-India Strategic Research Fund (AISRF) has funded six new projects, including one to develop COVID-19 diagnostic technologies and another study of the longer-term effects on the hearts and lungs of patients who have recovered.
Other projects will develop risk management systems to protect farmers from disasters associated with climate change and demonstrate how food-drying technology using renewable energy can reduce pollution in the food-processing sector.
Advertisement
It was a small but telling illustration of the gap between public expectations of the eagerly-anticipated new COVID-19 vaccines and the long, unpredictable road still ahead.
On Wednesday, federal acting Chief Medical Officer, Professor Paul Kelly, revealed that an “old friend” had emailed to see if his daughter, working in intensive care in Britain, might be allowed to return to Australia without quarantine because she’d received a first dose of the Pfizer-BioBTech vaccine – which British authorities had started rolling out only days before. An “interesting” proposition, Kelly said tactfully.
Get that jab: Healthcare workers wait to receive the Pfizer-BioNTech COVID-19 vaccine at UCI Medical Centre in California on Wednesday.
Illicit online wildlife trade continues despite pandemic miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.